/AYUR.CN
AYUR.CN Stock - Ayurcann Holdings Corp.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$0.02-20.00%
$0.01 (-20.00%) • Jan 14
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.7
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.50
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AYUR.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.02
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.74
52W High$0.04
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $31.11M | $25.16M | $12.49M | $9.39M | $7.63M |
| Gross Profit | $10.16M | $8.46M | $3.68M | $2.22M | $4.63M |
| Gross Margin | 32.7% | 33.6% | 29.5% | 23.7% | 60.6% |
| Operating Income | $-2,823,013 | $-3,251,000 | $-5,344,000 | $-3,332,000 | $2.16M |
| Net Income | $-3,485,784 | $-3,968,000 | $-5,307,000 | $-3,088,000 | $-278,000 |
| Net Margin | -11.2% | -15.8% | -42.5% | -32.9% | -3.6% |
| EPS | $-0.02 | $-0.02 | $-0.04 | $-0.03 | $-0.00 |
Company Overview
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers end-to-end outsourcing solutions, including extraction and refinement, bulk distillate oil sales, formulation and white label manufacturing, and fulfillment and distribution, as well as customized packaging solutions and inventory management services. It also provides medicinal cannabis, such as tincture, vapes, and topicals. In addition, the company operates Ayurcann marketplace, an online cannabis market for medical cannabis consumers. The company was founded in 2018 and is headquartered in Pickering, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AYUR.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 14, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q4 2025 | Nov 28, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 16, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 26, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 27, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 28, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 29, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 29, 2023 | — | $-0.01 | — | — |
Q1 2023 | Feb 27, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 29, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 26, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 22, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 29, 2021 | — | $0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.01 | — | — |
Q2 2021 | May 18, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AYUR.CN
What is AYUR.CN's current stock price?
Ayurcann Holdings Corp. (AYUR.CN) is currently trading at $0.02 per share. The stock has moved -20.00% today.
What is the analyst price target for AYUR.CN?
No analyst price targets are currently available for this stock.
What sector is Ayurcann Holdings Corp. in?
Ayurcann Holdings Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is AYUR.CN's market cap?
Ayurcann Holdings Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AYUR.CN pay dividends?
No, Ayurcann Holdings Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVNT.TO
Avant Brands Inc.
$0.95
Mkt Cap: $0.0B
CANB.V
CanadaBis Capital Inc.
$0.03
Mkt Cap: $0.0B
CLSH.CN
CLS Holdings USA, Inc.
$0.04
Mkt Cap: $0.0B
CTX.TO
Crescita Therapeutics Inc.
$0.50
Mkt Cap: $0.0B
LOBE.CN
Lobe Sciences Ltd.
$0.06
Mkt Cap: $0.0B
MUSH.V
Mercanto Holdings Inc.
$0.15
Mkt Cap: $0.0B
MVMD.CN
Mountain Valley MD Holdings Inc.
$0.02
Mkt Cap: $0.0B
MYCO.NE
Mydecine Innovations Group Inc.
$0.35
Mkt Cap: $0.0B
PWR.CN
Captiva Verde Wellness Corp.
$0.04
Mkt Cap: $0.0B
TGIF.CN
1933 Industries Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to AYUR.CN for comparison